Header

UZH-Logo

Maintenance Infos

The ORMDL3 asthma susceptibility gene regulates systemic ceramide levels without altering key asthma features in mice


Debeuf, Nincy; Zhakupova, Assem; Steiner, Regula; Van Gassen, Sofie; Deswarte, Kim; Fayazpour, Farzaneh; Van Moorleghem, Justine; Vergote, Karl; Pavie, Benjamin; Lemeire, Kelly; Hammad, Hamida; Hornemann, Thorsten; Janssens, Sophie; Lambrecht, Bart N (2019). The ORMDL3 asthma susceptibility gene regulates systemic ceramide levels without altering key asthma features in mice. Journal of Allergy and Clinical Immunology, 144(6):1648-1659.e9.

Abstract

BACKGROUND: Genome-wide association studies in asthma have repeatedly identified single nucleotide polymorphisms in the ORM (yeast)-like protein isoform 3 (ORMDL3) gene across different populations. Although the ORM homologues in yeast are well-known inhibitors of sphingolipid synthesis, it is still unclear whether and how mammalian ORMDL3 regulates sphingolipid metabolism and whether altered sphingolipid synthesis would be causally related to asthma risk.
OBJECTIVE: We sought to examine the in vivo role of ORMDL3 in sphingolipid metabolism and allergic asthma.
METHODS: Ormdl3-LacZ reporter mice, gene-deficient Ormdl3$^{-/-}$ mice, and overexpressing Ormdl3$^{Tg/wt}$ mice were exposed to physiologically relevant aeroallergens, such as house dust mite (HDM) or Alternaria alternata, to induce experimental asthma. Mass spectrometry-based sphingolipidomics were performed, and airway eosinophilia, T$_{H}$2 cytokine production, immunoglobulin synthesis, airway remodeling, and bronchial hyperreactivity were measured.
RESULTS: HDM challenge significantly increased levels of total sphingolipids in the lungs of HDM-sensitized mice compared with those in control mice. In Ormdl3$^{Tg/wt}$ mice the allergen-induced increase in lung ceramide levels was significantly reduced, whereas total sphingolipid levels were not affected. Conversely, in liver and serum, levels of total sphingolipids, including ceramides, were increased in Ormdl3$^{-/-}$ mice, whereas they were decreased in Ormdl3$^{Tg/wt}$ mice. This difference was independent of allergen exposure. Despite these changes, all features of asthma were identical between wild-type, Ormdl3$^{Tg/wt}$, and Ormdl3$^{-/-}$ mice across several models of experimental asthma.
CONCLUSION: ORMDL3 regulates systemic ceramide levels, but genetically interfering with Ormdl3 expression does not result in altered experimental asthma.

Abstract

BACKGROUND: Genome-wide association studies in asthma have repeatedly identified single nucleotide polymorphisms in the ORM (yeast)-like protein isoform 3 (ORMDL3) gene across different populations. Although the ORM homologues in yeast are well-known inhibitors of sphingolipid synthesis, it is still unclear whether and how mammalian ORMDL3 regulates sphingolipid metabolism and whether altered sphingolipid synthesis would be causally related to asthma risk.
OBJECTIVE: We sought to examine the in vivo role of ORMDL3 in sphingolipid metabolism and allergic asthma.
METHODS: Ormdl3-LacZ reporter mice, gene-deficient Ormdl3$^{-/-}$ mice, and overexpressing Ormdl3$^{Tg/wt}$ mice were exposed to physiologically relevant aeroallergens, such as house dust mite (HDM) or Alternaria alternata, to induce experimental asthma. Mass spectrometry-based sphingolipidomics were performed, and airway eosinophilia, T$_{H}$2 cytokine production, immunoglobulin synthesis, airway remodeling, and bronchial hyperreactivity were measured.
RESULTS: HDM challenge significantly increased levels of total sphingolipids in the lungs of HDM-sensitized mice compared with those in control mice. In Ormdl3$^{Tg/wt}$ mice the allergen-induced increase in lung ceramide levels was significantly reduced, whereas total sphingolipid levels were not affected. Conversely, in liver and serum, levels of total sphingolipids, including ceramides, were increased in Ormdl3$^{-/-}$ mice, whereas they were decreased in Ormdl3$^{Tg/wt}$ mice. This difference was independent of allergen exposure. Despite these changes, all features of asthma were identical between wild-type, Ormdl3$^{Tg/wt}$, and Ormdl3$^{-/-}$ mice across several models of experimental asthma.
CONCLUSION: ORMDL3 regulates systemic ceramide levels, but genetically interfering with Ormdl3 expression does not result in altered experimental asthma.

Statistics

Citations

Dimensions.ai Metrics
1 citation in Web of Science®
1 citation in Scopus®
Google Scholar™

Altmetrics

Additional indexing

Item Type:Journal Article, refereed, original work
Communities & Collections:04 Faculty of Medicine > University Hospital Zurich > Institute of Clinical Chemistry
Dewey Decimal Classification:610 Medicine & health
540 Chemistry
Language:English
Date:December 2019
Deposited On:05 Feb 2020 18:18
Last Modified:05 Feb 2020 18:18
Publisher:Elsevier
ISSN:0091-6749
OA Status:Closed
Free access at:Publisher DOI. An embargo period may apply.
Publisher DOI:https://doi.org/10.1016/j.jaci.2019.06.041
PubMed ID:31330218

Download

Full text not available from this repository.
View at publisher

Get full-text in a library